Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 7.48%80.140.8%$953.47m
MDTMedtronic Plc 2.59%92.220.6%$926.21m
TMOThermo Fisher Scientific, Inc. 1.74%279.121.0%$899.59m
ISRGIntuitive Surgical, Inc. 1.22%496.372.4%$714.92m
DHRDanaher Corp. -0.57%137.800.7%$703.57m
BDXBecton, Dickinson & Co. 1.26%219.311.1%$654.96m
SYKStryker Corp. 0.17%158.911.3%$568.15m
INOInovio Pharmaceuticals, Inc. 2.77%8.556.8%$504.95m
BSXBoston Scientific Corp. -1.44%30.171.1%$485.79m
EWEdwards Lifesciences Corp. -2.62%192.961.2%$445.02m
DXCMDexCom, Inc. 3.65%272.568.2%$397.35m
BAXBaxter International, Inc. 2.42%81.721.8%$385.11m
ZBHZimmer Biomet Holdings, Inc. -0.75%94.231.7%$256.87m
ALGNAlign Technology, Inc. -0.80%175.636.4%$252.66m
IDXXIDEXX Laboratories, Inc. 2.70%238.003.8%$242.40m

Company Profile

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.